Back to All

Diaceutics PLC announces it will release its preliminary results for last year on March 16

27 February, 2020

Diaceutics PLC (AIM: DXRX), the diagnostic commercialisation company, announces it will release its preliminary results for the year ended 31 December 2019 on Monday 16 March 2020.

Analyst briefing
The Company will host a briefing for analysts which will take place at 9.30am on Monday 16 March 2020 in the City of London. If you would like to register, please contact Walbrook PR on 020 7933 8780 or email [email protected].

Investor Briefing
The Company will host a private investor event which will take place on Monday 16 March at the Copper Bar, Balls Brothers, 6 Adams Court, London EC2N 1DX at 4.30pm for a 4.45pm start. This will be followed by drinks and canapés, and a chance to network with the management.

Peter Keeling, CEO, will update investors on the Company’s preliminary results and provide an overview of the business.

If you would like to register to attend the investor briefing or require further information, please contact Walbrook PR on 020 7933 8780 or email [email protected].

About Diaceutics

At Diaceutics we believe that every patient should get the precision medicine they deserve. We are a data analytics and end-to-end services provider enabled by DXRX - the world’s first Network solution for the development and commercialization of precision medicine diagnostics. 

Diaceutics has worked on every precision medicine brought to market and provides services to 36 of the world’s leading pharmaceutical companies. We have built the world’s largest repository of diagnostic testing data with a growing network of 2500 labs in 51 countries.